Literature DB >> 8140184

Erythrocyte membrane phospholipids in psychotic patients.

M S Keshavan1, A G Mallinger, J W Pettegrew, C Dippold.   

Abstract

Thin layer chromatography and laser densitometry were used to examine erythrocyte membrane phospholipid composition in 13 medication-free patients with schizophrenia or schizoaffective disorder and 11 healthy control subjects. The patient group had significantly decreased levels of phosphatidylethanolamine and a significant increase in sphingomyelin. The patient group also showed a trend toward decreased levels of phosphatidylinositol bisphosphate. Levels of phosphatidylcholine and lysophosphatidylcholine did not significantly differ between groups. There were no significant effects of age, body mass index, or gender on any of the phospholipid parameters. The observed alterations may point to abnormalities in key membrane-related functions, including signal transduction and ion transport.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8140184     DOI: 10.1016/0165-1781(93)90032-c

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  11 in total

1.  Impaired metabolic reactivity to oxidative stress in early psychosis patients.

Authors:  Margot Fournier; Carina Ferrari; Philipp S Baumann; Andrea Polari; Aline Monin; Tanja Bellier-Teichmann; Jacob Wulff; Kirk L Pappan; Michel Cuenod; Philippe Conus; Kim Q Do
Journal:  Schizophr Bull       Date:  2014-03-31       Impact factor: 9.306

2.  Fish oil and antipsychotic drug risperidone modulate oxidative stress in PC12 cell membranes through regulation of cytosolic calcium ion release and antioxidant system.

Authors:  Sevil Altinkiliç; Mustafa Naziroğlu; Abdülhadi Cihangir Uğuz; Ramazan Ozcankaya
Journal:  J Membr Biol       Date:  2010-06-24       Impact factor: 1.843

Review 3.  Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.

Authors:  J K Yao; R D Reddy; D P van Kammen
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  Impaired Membrane Lipid Homeostasis in Schizophrenia.

Authors:  Minghui Li; Yan Gao; Dandan Wang; Xiaowen Hu; Jie Jiang; Ying Qing; Xuhan Yang; Gaoping Cui; Pengkun Wang; Juan Zhang; Liya Sun; Chunling Wan
Journal:  Schizophr Bull       Date:  2022-09-01       Impact factor: 7.348

5.  A simple solid-phase extraction method for the analysis of red cell phospholipids by liquid chromatography- tandem mass spectrometry.

Authors:  Van Long Nguyen
Journal:  J Clin Lab Anal       Date:  2018-02-25       Impact factor: 2.352

Review 6.  Cognition, dopamine and bioactive lipids in schizophrenia.

Authors:  Ruth Condray; Jeffrey K Yao
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

7.  Genetic Sources of Subcomponents of Event-Related Potential in the Dimension of Psychosis Analyzed From the B-SNIP Study.

Authors:  Balaji Narayanan; Lauren E Ethridge; Kasey O'Neil; Sabra Dunn; Ian Mathew; Neeraj Tandon; Vince D Calhoun; Gualberto Ruaño; Mohan Kocherla; Andreas Windemuth; Brett A Clementz; Carol A Tamminga; John A Sweeney; Matcheri S Keshavan; Godfrey D Pearlson
Journal:  Am J Psychiatry       Date:  2015-01-23       Impact factor: 18.112

Review 8.  Ceramide and Its Related Neurochemical Networks as Targets for Some Brain Disorder Therapies.

Authors:  Justyna Brodowicz; Edmund Przegaliński; Christian P Müller; Malgorzata Filip
Journal:  Neurotox Res       Date:  2017-08-25       Impact factor: 3.911

9.  Effects of Psychostimulants and Antipsychotics on Serum Lipids in an Animal Model for Schizophrenia.

Authors:  Banny Silva Barbosa Correia; João Victor Nani; Raniery Waladares Ricardo; Danijela Stanisic; Tássia Brena Barroso Carneiro Costa; Mirian A F Hayashi; Ljubica Tasic
Journal:  Biomedicines       Date:  2021-02-26

10.  Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics.

Authors:  Joseph McEvoy; Rebecca A Baillie; Hongjie Zhu; Peter Buckley; Matcheri S Keshavan; Henry A Nasrallah; George G Dougherty; Jeffrey K Yao; Rima Kaddurah-Daouk
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.